Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
JAMA Psychiatry|October 25, 2023
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?Sanjay J Mathew, Manish K Jha, Amit Anand
The American Journal of Psychiatry|May 2, 2022
An Update on Community Ketamine PracticesBrittany O'Brien, Samuel T Wilkinson, Sanjay J Mathew
Journal of Affective Disorders|November 30, 2019
Q-15 checks and 1:1 observations: Exacerbating a problem we are trying to solve?Afsoon Gazor, Sanjay J Mathew, Michelle A Patriquin
Thyroid : Official Journal of the American Thyroid Association|May 1, 2026
Does Thyroid Hormone Boost Energy and Plasticity in the Brain as a Mechanism of Action in Antidepressant Augmentation Therapy?Roger McIntyre, Sanjay J Mathew, Thomas S Scanlan
Nature Reviews. Drug Discovery|March 18, 2017
Targeting glutamate signalling in depression: progress and prospectsJames W Murrough, Chadi G Abdallah, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulationDani Dumitriu, Kate Collins, Ron Alterman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 4, 2008
Novel drugs and therapeutic targets for severe mood disordersSanjay J Mathew, Husseini K Manji, Dennis S Charney
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 17, 2008
Recent advances in the neurobiology of anxiety disorders: implications for novel therapeuticsSanjay J Mathew, Rebecca B Price, Dennis S Charney
Biological Psychiatry|November 20, 2002
Molecular targets in the treatment of anxietyJustine M Kent, Sanjay J Mathew, Jack M Gorman
Current Psychiatry Reports|August 27, 2015
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other ApproachesRayan K Al Jurdi, Alan Swann, Sanjay J Mathew
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
JAMA Psychiatry|October 25, 2023
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?Sanjay J Mathew, Manish K Jha, Amit Anand
The American Journal of Psychiatry|May 2, 2022
An Update on Community Ketamine PracticesBrittany O'Brien, Samuel T Wilkinson, Sanjay J Mathew
Journal of Affective Disorders|November 30, 2019
Q-15 checks and 1:1 observations: Exacerbating a problem we are trying to solve?Afsoon Gazor, Sanjay J Mathew, Michelle A Patriquin
Thyroid : Official Journal of the American Thyroid Association|May 1, 2026
Does Thyroid Hormone Boost Energy and Plasticity in the Brain as a Mechanism of Action in Antidepressant Augmentation Therapy?Roger McIntyre, Sanjay J Mathew, Thomas S Scanlan
Nature Reviews. Drug Discovery|March 18, 2017
Targeting glutamate signalling in depression: progress and prospectsJames W Murrough, Chadi G Abdallah, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulationDani Dumitriu, Kate Collins, Ron Alterman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 4, 2008
Novel drugs and therapeutic targets for severe mood disordersSanjay J Mathew, Husseini K Manji, Dennis S Charney
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 17, 2008
Recent advances in the neurobiology of anxiety disorders: implications for novel therapeuticsSanjay J Mathew, Rebecca B Price, Dennis S Charney
Biological Psychiatry|November 20, 2002
Molecular targets in the treatment of anxietyJustine M Kent, Sanjay J Mathew, Jack M Gorman
Current Psychiatry Reports|August 27, 2015
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other ApproachesRayan K Al Jurdi, Alan Swann, Sanjay J Mathew
Pageof 19